133 related articles for article (PubMed ID: 27464)
1. Assessment of beta-blocking activity of trimepranol in man.
Pentikäinen PJ; Neuvonen PJ; Penttilä A
Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the activity of beta-adrenoceptor antagonists in man.
Taylor SH; Thadani U; Davidson C; singleton W; Myint S
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
[TBL] [Abstract][Full Text] [Related]
3. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
Adam KR; Pullman LG; Scholfield PC
Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effect of trimepranol, a new beta-blocking agent.
Jounela AJ; Pentikäinen PJ; Neuvonen PJ
Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):183-8. PubMed ID: 25847
[TBL] [Abstract][Full Text] [Related]
5. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
Aellig WH
Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
[No Abstract] [Full Text] [Related]
6. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
Bodem G; Brammell HL; Weil JV; Chidsey CA
J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
[TBL] [Abstract][Full Text] [Related]
7. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
Femmer K
Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
[No Abstract] [Full Text] [Related]
8. Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.
Graham BR; Littlejohns DW; Prichard BN; Scales B; Southorn P
Br J Pharmacol; 1973 Sep; 49(1):154P-155P. PubMed ID: 4150762
[No Abstract] [Full Text] [Related]
9. [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].
Mayer O; Petrlík M; Vitous J; Cepelák V
Vnitr Lek; 1976 Nov; 22(11):1102-9. PubMed ID: 12612
[No Abstract] [Full Text] [Related]
10. [Change of the reactibility of the myocardium following the termination of the beta-blocking effect of trimepranol and practolol].
Svec P; Inczinger F; Béderová E; Zigová L
Cesk Farm; 1977 May; 26(4):128-30. PubMed ID: 880637
[No Abstract] [Full Text] [Related]
11. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
[TBL] [Abstract][Full Text] [Related]
12. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
Bartsch W; Dietmann K; Leinert H; Sponer G
Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
[TBL] [Abstract][Full Text] [Related]
13. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
[TBL] [Abstract][Full Text] [Related]
15. [Effects of metoprolol, practolol, and propranolol after isoprenaline injections in asthmatic patients (author's transl)].
Svedmyr N; Thiringer G
Sem Hop; 1980 Apr 18-25; 56(15-16):798-804. PubMed ID: 6246620
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
17. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
Mayer O; Cepelák V; Vitous J; Potmĕsil J
Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
[No Abstract] [Full Text] [Related]
18. The effect of trimepranol on the binding of [3H] norepinephrine in myocardial subcellular fractions of the dog.
Nedvídková J; Felt V
Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):208-11. PubMed ID: 9036
[TBL] [Abstract][Full Text] [Related]
19. Comparative potency of intravenous penbutolol and propranolol in man.
Sharma PL; Sapru RP
Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man.
Miki N; Furusho Y; Itaya K; Midorikawa K; Kumagai E; Terasawa M; Ihara S; Matoba T; Toshima H
Jpn Circ J; 1980 Oct; 44(10):783-93. PubMed ID: 6107392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
